Epidemiological and animal studies revealed that capsaicin can act as a carcinogen or cocarcinogen. However, the molecular mechanisms of the cancer-promoting effects of capsaicin are not clear. Here, we report that capsaicin has a co-carcinogenic effect on 12-Otetradecanoylphorbol-13-acetate (TPA)-promoted skin carcinogenesis in vivo and is mediated through the epidermal growth factor receptor (EGFR), but not the transient receptor potential ERKs activation in A431 cells was dependent on EGFR, but not TRPV1. Together, these findings suggest that capsaicin might act as a co-carcinogen in TPA-induced skin carcinogenesis through EGFR-dependent mechanisms.
Introduction
Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a principal pungent ingredient of Capsicum fruits, which are widely consumed worldwide. It is used in topical creams and its role in carcinogenesis is controversial. Capsaicin induces apoptosis of cancers cells, including myeloid leukemia (1), human hepatoma (2) , and colon cancer (3) . However, epidemiological and animal experimental evidence suggests that capsaicin also acts as a carcinogen or co-carcinogen, particularly during the tumor promotion stage (4) . Capsaicin from chili peppers promoted stomach and liver cancer in BALB/c mice (5) and also induced duodenal adenocarcinoma in mice (6) . Epidemiological studies suggested a positive association between the incidence of stomach cancer and the consumption of chili pepper-rich diets (7) . Capsaicin enhanced the metastasis of murine breast cancer cells by reducing expression of apoptosis-related genes (8) and induced LNCaP prostate cancer cell proliferation by increasing androgen receptor expression through the activation of ERKs and Akt (9) . Thus, clarifying the underlying molecular mechanisms to reveal whether or not capsaicin exerts carcinogenic activities is important.
Transient receptor potential vanilloid subfamily member 1 (TRPV1) is a ligand-gated cation channel with limited selectivity for calcium ions. TRPV1 is activated by noxious stimuli including heat, acid, and vanilloid compounds like capsaicin (10) . Capsaicin is a selective agonist of TRPV1 and causes TRPV1 to be desensitized after activation. TRPV1 is widely expressed in primary afferent neurons and also in non-neuronal tissues, including skin keratinocytes, fibroblasts, liver, prostate, and bladder smooth muscle (11) . Thus studying the function of TRPV1 in a broader context than pain perception is relevant. Although the biological role of TRPV1 in cells other than primary sensory neurons is unclear, some studies indicated a In contrast, treatment with only capsaicin or vehicle did not induce any skin tumors in either TRPV1/WT or KO mice ( Table 1; Fig. 1C ), indicating that capsaicin alone does not act as a carcinogen. All mice (100%) in both groups developed papillomas in response to TPA and capsaicin by 21 weeks (Fig. 1D) , whereas about 20% of WT mice vs. 75% of TRPV1 knockout mice developed tumors in response to TPA only ( Table 1 and ref (15) ). These results suggest that capsaicin might act as a co-carcinogen through TRPV1-independent mechanisms.
Capsaicin increases TPA-induced COX-2 expression more strongly in TRPV1/KO mice. Increased amounts of COX-2 are commonly found in both malignant tissues and tumors, including skin cancer (20) . We examined COX-2 protein abundance in tumors extracted from mouse skin. Both TRPV1/WT and KO mice treated with capsaicin and TPA together exhibited higher COX-2 protein levels than groups treated with TPA alone ( Fig. 2A) and tumors from TRPV1/KO mice expressed the highest level of COX-2 as a result of treatment with capsaicin and TPA together ( Fig. 2A) . Western blot results confirmed that tumor lysates from TRPV1/KO mice treated with capsaicin and TPA exhibited significantly higher levels of COX-2 than TRPV1/WT mice (Fig. 2B) . Additionally, tumors from TRPV1/KO mice co-treated with capsaicin and TPA exhibited higher COX-2 expression levels compared to mice treated with TPA alone (Fig. 2C) . These results suggest that capsaicin acts through a TRPV1-independent mechanism to induce COX-2 expression in the presence of TPA.
Capsaicin increases TPA-induced COX-2 expression in TRPV1/KO cells. Genomic (Fig. 3A) . In addition, elevated COX-2 expression levels were seen in response to co-treatment with capsaicin and TPA in TRPV1/KO MEFs (Fig. 3B) . To determine the signaling molecules involved in COX-2 up-regulation by capsaicin and TPA, chemical inhibitors for EGFR and downstream MEK signals were used. AG1478 (an EGFR inhibitor) and U0126 (an MEK inhibitor) distinctly suppressed TPA/capsaicin-induced COX-2 expression in TRPV1/KO MEFs, suggesting a possible role of the EGFR pathway in capsaicin-induced COX-2 up-regulation when TRPV1 is depleted (Fig. 3C) . We then determined the inhibitory effect of AG1478 on the phosphorylation of MEK, one of the direct downstream substrates of EGFR, and that of U0126 on the phosphorylation of ERKs, a direct downstream substrate of MEK.
TPA/capsaicin-induced phosphorylations of MEK and ERK were suppressed by AG1478 and U0126, respectively, suggesting that each inhibitor blocks its respective target in this cell system (Fig. 3D) .
EGFR is involved in TPA/capsaicin-promoted COX-2 expression. We next compared the effect of capsaicin on TPA-induced COX-2 expression in EGFR/WT and KO MEFs. EGFR was only detected in EGFR/WT MEFs (Fig. 4A) . Treatment with capsaicin alone did not induce COX-2 expression when EGFR was depleted (Fig. 4B) . Similarly, TPA-induced COX-2 expression was only increased by capsaicin in EGFR/WT MEFs (Fig. 4C) . To determine whether TPA-induced COX-2 expression is regulated by capsaicin at the transcriptional or posttranscriptional level, we measured cox-2 mRNA level using RT-PCR. Capsaicin upregulated cox-2 mRNA expression more strongly than TPA alone, and the TPA/capsaicin-induced cox-2 mRNA (Fig. 4D) . These results indicate that cox-2 is upregulated by TPA/capsaicin treatment at the transcriptional level and support the idea that capsaicin-induced COX-2 expression is dependent on the EGFR pathway.
EGFR downstream signaling is sustainably activated in response to TPA and capsaicin only in the presence of EGFR. After the activation of EGFR, several intracellular signaling pathways, including ERK and PI3K/Akt, are recruited to EGFR and subsequently activated (21) .
Co-treatment with capsaicin and TPA induced phosphorylation of ERKs and Akt in EGFR/WT MEFs more strongly than in EGFR/KO MEFs (Fig. 5A) . The more time that passed after cotreatment with TPA and capsaicin, the more strongly sustained was the phosphorylation of ERKs and Akt in EGFR/WT MEFs (Fig. 5B) . In EGFR/KO cells, however, TPA/capsaicin treatment had little effect on ERKs or Akt phosphorylation, indicating that EGFR plays a key role in capsaicin-induced activation of downstream intracellular signal pathways.
Activation of EGFR signaling in response to TPA and capsaicin is dependent on both EGFR and Src activation. Treatment with AG1478 or PP2 (an Src inhibitor) showed that sustained activation of ERKs and Akt was still dependent on EGFR activation but also on Src (Fig. 5C) . Next, tyrosine phosphorylation of EGFR was determined by immunoprecipitating cells with anti-EGFR and subsequent immunoblotting with a phospho-tyrosine antibody.
Treatment with TPA and capsaicin together induced phosphorylation of EGFR at tyrosine residues ( Fig. 5D, upper) . Because EGFR was reported to be activated intracellularly by Src kinase, we next examined the effect of PP2 on TPA/capsaicin-induced EGFR phosphorylation 3A ). Through the activation of EGFR, capsaicin induces phosphorylation of downstream effectors including ERKs in A431 cells (Supplemental Fig. 3B) . To reveal the mechanism involved in capsaicin-induced ERKs phosphorylation, we used EGFR inhibitors and TRPV1
antagonists. The results indicated that capsaicin-induced ERKs phosphorylation was dependent on EGFR activation, but independent of TRPV1 activation (Supplemental Fig. 3C ). To further reveal whether capsaicin-induced EGFR activation is dependent on Src and MMP activations, we examined the effect of PP2 and GM6001 (an MMP inhibitor). Capsaicin-induced EGFR phosphorylation was inhibited by PP2 or GM6001 (Supplemental Fig. 3D ), suggesting that capsaicin induces EGFR phosphorylation through the activations of Src and MMP.
Discussion
TRPV1 is involved in the regulation of pain pathways (24) . Capsaicin initially activates TRPV1 and excites nociceptive neurons, leading to the perception of pain. However, prolonged and repetitive exposure to capsaicin causes TRPV1 to become insensitive to noxious stimuli, resulting in desensitization (10) . Thus, capsaicin-containing drugs have been developed to treat neuropathic pain through topical administration. Accumulating evidence suggests that repeated or high-dose treatments of capsaicin can cause apoptosis of TRPV1-expressing cells, primarily through the elevation of intracellular calcium ion levels (25) , indicating that TRPV1- 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Copyright © 2010 American Association for Cancer Research unresponsive or deficient states might be clinically important with exposure to capsaicin for a prolonged period. Because capsaicin-induced initial activation of TRPV1 is inevitably followed by desensitization, the possibility that capsaicin affects intracellular signals independently of TRPV1 cannot be excluded (26) . TRPV1 expression was reportedly reduced in aged mice, an effect that corresponded with loss of noxious sensitivity in aging animals (27) . Thus, to determine the effects and target proteins of capsaicin when TRPV1 is physiologically absent is important.
TRPV1 is distributed widely in many cell types other than sensory neurons (11) . In skin, TRPV1 is also expressed in keratinocytes and fibroblasts (28) . TRPV1 activation is involved in inflammatory responses in human keratinocytes through the release of inflammatory mediators, such as prostaglandin E 2 (PGE 2 ) and interleukin-8 (28), and UV irradiation-increased MMP-1 is mediated by TRPV1 in keratinocytes (29) . In contrast, keratinocytes were reportedly resistant to vanilloid-induced TRPV1 activation and subsequent calcium influx (30) . In our previous studies we confirmed that TRPV1 expression was depleted in skin cancer tissues, and lack of TRPV1 corresponded with increased incidence of mouse skin cancer development mediated by high levels of EGFR (15) . These results indicated that agents activating EGFR signaling could lead to the induction of skin tumors in TRPV1/KO mice. In the present study, we found that capsaicin induced DMBA-initiated and TPA-promoted skin carcinogenesis more readily in TRPV1/KO mice than in WT mice, through the up-regulation of COX-2 expression, and EGFR signaling was involved in capsaicin-induced COX-2 expression in the absence of TRPV1. TRPV1 has been considered as an inflammatory receptor based on the findings that nociception and proinflammatory mediators are evoked through the activation of TRPV1 (24) . In addition, TRPV1 Even though epidemiological studies suggested a positive association between the consumption of capsaicin or chili pepper-rich diets and the incidence of cancers in human, whether the EGFR activation caused by capsaicin is involved is not clear. Among many cancers, accumulating evidence focused on the causative effects of capsaicin-containing diets on stomach or gallbladder cancers (7, 37) . Stomach cancer is a major cancer expressing high levels of EGFR.
According to a recent human study in Chinese gastric carcinoma patients, about 42% of cases showed an elevated expression level of EGFR (38) . Another study also revealed that EGFR overexpression was detected in patients with gastric carcinoma, which was associated with an unfavorable prognosis (39) . Similarly, EGFR overexpression is frequently reported in gallbladder cancer patients (40) . Our present findings that EGFR activation induced by capsaicin in skin cancer leads to a cancer promoting effect underlies the relevance of epidemiological reports of capsaicin to the incidence of EGFR-overexpressed human cancers.
Spice-derived phytochemicals including capsaicin have suggested potential chemopreventive effects (41) . Anti-carcinogenic effects of capsaicin are achieved through various mechanisms, including apoptosis (42). A major mechanism by which capsaicin exhibits its anti-carcinogenic effects might be the inhibition of NF-κB and STAT3 activation. Capsaicin was reported to block NF-κB activation induced by diverse agents including phorbol esters in leukemia cells (43) and in the two-stage skin carcinogenesis model (44, 45 
Copyright © 2010 American Association for Cancer Research found to block STAT3 activation and downregulate STAT3-dependent gene products including cyclin D1, Bcl-2, and survivin (46) . Although our study indicates that capsaicin might act as a co-carcinogen in the DMBA/TPA-promoted skin cancer model, the anti-carcinogenic potential of capsaicin cannot be excluded.
A recent study assessing the oncogenic potential of capsaicin revealed that dermal application of capsaicin did not lead to the induction of preneoplastic or neoplastic skin lesions in the Tg.Ac mouse model (47) . Consistent with this result, our study showed that capsaicin alone did not cause skin carcinogenesis. Capsaicin was reported to cause a burning sensation and skin irritation when applied topically and to induce the erosion of gastric mucosa and hepatic necrosis when administrated in large amounts (48) . Although capsaicin can induce cancer cell death, it can also cause kill normal neuronal cells (49) . Although whether capsaicin has genotoxic and carcinogenic effects remains controversial, evidence supports these suspected adverse effects of capsaicin. We found that might act as a co-carcinogen by inducing the sustained activation of EGFR downstream signals, through activation of EGFR. Capsaicin might promote cancer cell survival in the absence of TRPV1 (14). Similar to capsaicin, tumor necrosis factor (TNF), is suspected to both induce and reduce cancer cell growth and was shown to commit cells to survival when stimulating EGFR transactivation mechanisms, indicating that EGFR can act as a molecular switch determining the anti-apoptotic effect of TNF (50) . Thus, capsaicin might commit tumors to survival and evade apoptosis in the absence of TRPV1 through the activation of EGFR. However, because capsaicin also is reported to induce proinflammatory signals through the activation of TRPV1 (28), the possibility that capsaicin induces inflammation and affects cancer development in a TRPV1-dependent manner cannot be excluded. 
